IBT
IMMU

International Biotechnology Trust’s Immunomedics Inc IMMU Stock Holding History

International Biotechnology Trust’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49,700
Closed -$4.22M – 57
2020
Q3 		$4.22M Sell
49,700
-398,300
-89% -$20.1M 1.36% 23
2020
Q2 		$15.3M Buy
448,000
+376,000
+522% +$11M 5.1% 5
2020
Q1 		$970K Buy
+72,000
New +$1.21M 0.44% 34

International Biotechnology Trust's IMMU Position: Q4 2020 in Review

International Biotechnology Trust sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 49,700 shares — an estimated $4.22M sold.

International Biotechnology Trust first reported a position in IMMU in Q1 2020 and held it in 3 quarters. The position peaked at $15.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • International Biotechnology Trust reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 49,700 Immunomedics Inc shares in Q4 2020, an estimated $4.22M.
  • International Biotechnology Trust first reported a position in Immunomedics Inc in Q1 2020 and held it in 3 quarters.
  • International Biotechnology Trust's Immunomedics Inc position peaked at $15.3M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on International Biotechnology Trust's 13F filing for Q4 2020, filed 19 Feb 2021.